GlobeNewswire

Ally Medical ER Wins Midsize Company Category for Fourth Straight Year in Austin American-Statesman Top Workplaces
12/11/2026
The freestanding emergency room also earned the Doer Award as it continues to grow across the greater Austin area AUSTIN, Texas, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room (Ally Medical ER), which [...]
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
12/11/2026
REVEAL pivotal and ASPIRE trials evaluating TSHA-102 for Rett syndrome ongoing; expect to report topline data from 6-month interim analysis and FDA feedback on BLA submission pathway in 1H 2027 TSHA-102 continues to be [...]
Jeff Leger, président-directeur général de 123Dentiste, et sa famille créent un fonds à la Faculté de médecine dentaire de l’Université Dalhousie pour mieux comprendre le lien entre santé buccodentaire et santé globale
12/11/2026
Le Fonds de recherche en santé buccodentaire de la famille Leger soutiendra des travaux visant à mieux comprendre les liens entre la santé buccodentaire, la santé globale et les maladies chroniques TORONTO, 12 nov. 2026 [...]
123Dentist CEO Jeff Leger and family establish fund at Dalhousie University’s Faculty of Dentistry to advance research into the connection between oral health and overall health
12/11/2026
The Leger Family Oral Health Research Fund will back research that deepens understanding of how oral health connects to overall health and chronic disease TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Jeff Leger, Chief [...]
Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials
12/11/2026
BD200 is a multibody drug conjugate, in which each arm of the antibody can alternatively bind to either Nectin-4 or Trop2, two validated oncology antigens that may be expressed on cancer cells Combined with a unique [...]
Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference
12/11/2026
WAYNE, Pa., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
12/11/2026
PCAOB audited FY2024 and FY2025 and reviewed unaudited six months ended June 30, 2026 financials of G3 and its consolidated subsidiaries (“G3”) delivered In FY 2025, the Combined G3 company had consolidated revenue of $ [...]
Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
12/11/2026
Registrational U.S. AURORA Phase 3 clinical trial underway for denifanstat in moderate to severe acne, with topline data anticipated in the second half of 2027 Positive denifanstat Phase 3 clinical trial results in [...]
Kamau Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Nula-cel, a Gene-Corrected Stem Cell Therapy for Sickle Cell Disease
12/11/2026
Designation based on preliminary clinical evidence from the Phase 1/2 RESTORE trial; nula-cel also holds Fast Track and Orphan Drug designations SOUTH SAN FRANCISCO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Kamau [...]
Grace Therapeutics Announces Second Quarter 2027 Financial Results, Provides Business Update
12/11/2026
PRINCETON, N.J., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage biopharma company advancing GTx-104, a novel, injectable formulation of [...]
Le signal de ralliement 2026 : L’élan prend de l’ampleur, mais trop de filles sont encore laissées en plan
12/11/2026
Réalisée en collaboration avec la Fondation Bon départ de Canadian Tire, la recherche phare de Femmes et sport au Canada révèle que les gains se sont maintenus pour la participation des filles au sport et propose des [...]
Rally Report 2026: The momentum is growing. But too many girls are still being left behind
12/11/2026
Canadian Women & Sport's flagship research, with Canadian Tire Jumpstart Charities, finds girls' sport participation has held its gains and points to what it will take to help more girls start and keep playing [...]
Annovis Bio Granted U.S. Patent Covering New Crystalline Form of Buntanetap
12/11/2026
U.S. Patent No. 12,780,831 covers posiphen (buntanetap) D-tartrate Form B, a highly crystalline dihydrate, together with pharmaceutical compositions and methods of preparation, providing protection through 2044 Form B [...]
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference 2026 in London
12/11/2026
BOSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
R1 Takes Aim at Healthcare’s Fragmented Revenue Cycle with Six Connected AI Solutions
12/11/2026
New Phare Denials module joins Phare OS, giving health systems a pathway from point solutions to a connected revenue operating system spanning pre- and post-bill operations Phare OS adoption now spans more than $275 [...]
Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights
12/11/2026
Initiated Phase 1 study of AP03, a fixed dose combination of nebulized pirfenidone and nintedanib, in healthy volunteers Presented new AP01 data at ERS Congress and published detailed results from AP02 Phase 1 trials in [...]
Vivani Medical Announces Positive Top-Line Results from SLIM-1™, a First in Human Phase 1 Trial of NPM-139 (semaglutide implant) and Wegovy (weekly semaglutide injections) in Obese and Overweight Subjects
12/11/2026
Strong NPM-139 safety and tolerability profile: -0 of 10 NPM-139 subjects experienced adverse events reported as treatment related -5 of 10 Wegovy subjects (control group) experienced adverse events reported as [...]
Artelo Biosciences Provides Business Update and Reports 2026 Third Quarter Financial Results
12/11/2026
Continued Progress Across Pipeline Supports Expanded Therapeutic Opportunities SOLANA BEACH, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”), a clinical [...]
Hyro Achieves Oracle Validated: Oracle Health Endpoint Validation Expertise for Delivering Proven Agentic AI EHR Integration
12/11/2026
Validation confirms Hyro’s Care OnCue™ appointment workflows run on Oracle Health’s existing interfaces, reducing custom integration effort and cost of ownership for health systems NEW YORK, Nov. 12, 2026 (GLOBE [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum